$4.54
0.040.89%
At Close: -
$4.28
-0.26-5.73%
After Hours: Sep 20, 8:44 AM EDT
15 minutes delayed
Comments
Loading...
Latest news for Monopar Therapeutics (NASDAQ:MNPR) Stock
Monopar Therapeutics Stock (NASDAQ: MNPR)
Categories: All
Thursday, September 12, 2024
Tuesday, August 27, 2024
Wednesday, August 21, 2024
Wednesday, August 14, 2024
Friday, August 09, 2024
Tuesday, June 25, 2024
Monday, June 24, 2024
Tuesday, June 11, 2024
Monday, June 10, 2024
Friday, June 07, 2024
Monday, June 03, 2024
Friday, May 24, 2024
Friday, May 10, 2024
Thursday, May 09, 2024
Friday, May 03, 2024
Thursday, April 18, 2024
Tuesday, April 16, 2024
Thursday, April 11, 2024
Wednesday, April 10, 2024
Thursday, March 28, 2024
Tuesday, March 19, 2024
Tuesday, March 05, 2024
Wednesday, February 28, 2024
Tuesday, February 27, 2024
Monday, February 26, 2024
Friday, February 23, 2024
Thursday, February 22, 2024
- Dow Gains Over 400 Points; Keurig Dr Pepper Shares Fall After Q4 Results
- Why Etsy Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- What's Going On With Cancer-Focused Monopar Therapeutics Stock Today?
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Crude Oil Rises 1%; US Jobless Claims Fall To 201,000
- Monopar Therapeutics shares are trading highe...
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Monopar Reports In-house Radiopharmaceutical Development Team Was Able To Significantly Increase Tumor Uptake Of MNPR-101-Zr While Minimizing Uptake In Healthy Tissue